These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 5795445)

  • 1. Gold sodium thiomalate in visceral leishmaniasis. Anti-leishmanial activity in hamsters.
    Abruzzo JL; DeHoratius RJ
    Am J Trop Med Hyg; 1969 Jul; 18(4):506-10. PubMed ID: 5795445
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of low doses of amphotericin B plus allicin against experimental visceral leishmaniasis.
    Corral MJ; Serrano DR; Moreno I; Torrado JJ; Domínguez M; Alunda JM
    J Antimicrob Chemother; 2014 Dec; 69(12):3268-74. PubMed ID: 25096077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A light and electron microscopic study of the distribution of gold sodium thiomalate in the rheumatoid synovial membranes.
    Inoue H
    Acta Med Okayama (1952); 1968 Dec; 22(6):293-317. PubMed ID: 4240918
    [No Abstract]   [Full Text] [Related]  

  • 4. Targeted chemotherapy of visceral leishmaniasis by lactoferrin-appended amphotericin B-loaded nanoreservoir: in vitro and in vivo studies.
    Asthana S; Gupta PK; Jaiswal AK; Dube A; Chourasia MK
    Nanomedicine (Lond); 2015; 10(7):1093-109. PubMed ID: 25929567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel mechanism for an old drug: amphotericin B in the treatment of visceral leishmaniasis.
    Chattopadhyay A; Jafurulla M
    Biochem Biophys Res Commun; 2011 Dec; 416(1-2):7-12. PubMed ID: 22100811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of targeted 1,2-diacyl-sn-glycero-3-phospho-l-serine-coated gelatin nanoparticles loaded with amphotericin B for improved in vitro and in vivo effect in leishmaniasis.
    Khatik R; Dwivedi P; Khare P; Kansal S; Dube A; Mishra PR; Dwivedi AK
    Expert Opin Drug Deliv; 2014 May; 11(5):633-46. PubMed ID: 24606222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [SOME PATHOMORPHOLOGICAL CHANGES IN EXPERIMENTAL LEISHMANIASIS IN CRICETULUS AURATUS IN INFECTION WITH THE CENTRAL ASIAN STRAINS OF LEISHMANIA CANIS AND LEISHMANIA TROPICA MAJOR].
    VAVILOVA MP; ALIMOV VA
    Med Parazitol (Mosk); 1963; 32():648-55. PubMed ID: 14159547
    [No Abstract]   [Full Text] [Related]  

  • 8. Liposomal amphotericin B in the treatment of visceral leishmaniasis.
    Croft SL; Davidson RN; Thornton EA
    J Antimicrob Chemother; 1991 Oct; 28 Suppl B():111-8. PubMed ID: 1778888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liposomal amphotericin B versus pentavalent antimony salts for visceral Leishmania in children.
    Apa H; Devrim İ; Bayram N; Deveci R; Demir-Özek G; Cartı ÖU
    Turk J Pediatr; 2013; 55(4):378-83. PubMed ID: 24292030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visceral spreading depletion of thymus-dependent regions and amyloidosis in mice and hamsters infected intradermally with Leishmania isolated from Sudanese cutaneous leishmaniasis.
    Veress B; Abdalla RE; El Hassan AM
    Br J Exp Pathol; 1983 Oct; 64(5):505-14. PubMed ID: 6605763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-leishmanial activity of a new formulation of amphotericin B.
    Dea-Ayuela MA; Rama-Iñiguez S; Sánchez-Brunete JA; Torrado JJ; Alunda JM; Bolás-Fernández F
    Trop Med Int Health; 2004 Sep; 9(9):981-90. PubMed ID: 15361111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of visceral leishmaniasis in children].
    Minodier P; Noël G; Blanc P; Uters M; Retornaz K; Garnier JM
    Med Trop (Mars); 2007 Feb; 67(1):73-8. PubMed ID: 17506279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo antileishmanial activity and histopathological evaluation in Leishmania infantum infected hamsters after treatment with a furoxan derivative.
    de Almeida L; Passalacqua TG; Dutra LA; Fonseca JNVD; Nascimento RFQ; Imamura KB; de Andrade CR; Dos Santos JL; Graminha MAS
    Biomed Pharmacother; 2017 Nov; 95():536-547. PubMed ID: 28866421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Injectable paromomycin for Visceral leishmaniasis in India.
    Sundar S; Jha TK; Thakur CP; Sinha PK; Bhattacharya SK
    N Engl J Med; 2007 Jun; 356(25):2571-81. PubMed ID: 17582067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-leishmanial activity of the bisnaphthalimidopropyl derivatives.
    Tavares J; Ouaissi A; Silva AM; Lin PK; Roy N; Cordeiro-da-Silva A
    Parasitol Int; 2012 Jun; 61(2):360-3. PubMed ID: 22155672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti leishmanial therapy--the changing scene.
    Bichile LS
    J Assoc Physicians India; 1994 Sep; 42(9):682-3. PubMed ID: 7883657
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on gold therapy with 198 gold sodium thiomalate.
    Oka Y
    Ryumachi; 1973 Jan; 12(4):311-23. PubMed ID: 4197520
    [No Abstract]   [Full Text] [Related]  

  • 18. Antileishmanial activity of nano-amphotericin B deoxycholate.
    Manandhar KD; Yadav TP; Prajapati VK; Kumar S; Rai M; Dube A; Srivastava ON; Sundar S
    J Antimicrob Chemother; 2008 Aug; 62(2):376-80. PubMed ID: 18453526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AA-amyloidosis caused by visceral leishmaniasis in a human immunodeficiency virus-infected patient.
    de Vallière S; Mary C; Joneberg JE; Rotman S; Bullani R; Greub G; Gillmore JD; Buffet PA; Tarr PE
    Am J Trop Med Hyg; 2009 Aug; 81(2):209-12. PubMed ID: 19635871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of antimony-resistant visceral leishmaniasis with liposomal amphotericin B in patients infected with human immunodeficiency virus.
    Torre-Cisneros J; Villanueva JL; Kindelan JM; Jurado R; Sanchez-Guijo P
    Clin Infect Dis; 1993 Oct; 17(4):625-7. PubMed ID: 8268341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.